PHARMACEUTICAL (III)

To provide a technique for inhibiting crystal deposition in a halogenated isoquinoline derivative-containing aqueous composition during low-temperature storage.SOLUTION: A pharmaceutical formulation for preventing or treating one or more diseases selected from ocular hypertension and glaucoma compri...

Full description

Saved in:
Bibliographic Details
Main Author SUGIMOTO MAKOTO
Format Patent
LanguageEnglish
Japanese
Published 03.12.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide a technique for inhibiting crystal deposition in a halogenated isoquinoline derivative-containing aqueous composition during low-temperature storage.SOLUTION: A pharmaceutical formulation for preventing or treating one or more diseases selected from ocular hypertension and glaucoma comprises an aqueous composition stored in a polyester based resin container, the aqueous composition containing a compound represented by the general formula (1) in the figure, where X represents a halogen atom, or its salt, or their solvate.SELECTED DRAWING: None 【課題】ハロゲン化イソキノリン誘導体含有水性組成物の、低温保存時の結晶析出を抑制する技術を提供すること。【解決手段】次の一般式（１）［式中、Ｘはハロゲン原子を示す。］で表される化合物若しくはその塩又はそれらの溶媒和物を含有する水性組成物が、ポリエステル系樹脂製容器に収容されてなる、高眼圧症及び緑内障から選ばれる１種以上の疾患の予防又は治療用の医薬製剤。【選択図】なし
Bibliography:Application Number: JP20200137370